Peter Mazzone, MD, MPH, Director of the Lung Cancer program, discusses USPSTF-backed changes to screening eligibility. Who qualifies, and how will this change your practice?
When high quality programs screen patients, the balance of benefit and harms tips toward lung cancer screening — cancers are detected sooner, and fewer unnecessary interventions occur.
Based on our experience at Cleveland Clinic, we favor centralized management of screening decisions in our health system, detailed and thorough shared decision-making visits with one-year follow up and concrete plans for managing incidental findings.
The low-dose chest CT scan used for lung cancer screening frequently demonstrates incidental findings in the anatomic structures imaged from the neck to the upper abdomen. This study describes the frequency of incidental findings and their clinical and financial downstream effects.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A centralized counseling and shared decision-making visit prior to lung cancer screening can help patients make value-based decisions about their care and ensure a lung cancer screening program is high quality and patient centered.